- Home
- Publications
- Publication Search
- Publication Details
Title
A Review on Dengue Vaccine Development
Authors
Keywords
-
Journal
Vaccines
Volume 8, Issue 1, Pages 63
Publisher
MDPI AG
Online
2020-02-04
DOI
10.3390/vaccines8010063
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of the oral immunogenicity of M cell-targeted tetravalent EDIII antigen for development of plant-based edible vaccine against dengue infection
- (2019) Byeong-Young Kim et al. PLANT CELL TISSUE AND ORGAN CULTURE
- Safety and Immunogenicity of a Tetravalent Dengue DNA Vaccine Administered with a Cationic Lipid-Based Adjuvant in a Phase 1 Clinical Trial
- (2018) Janine R. Danko et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Comparative immunogenicity of preparations of yeast-derived dengue oral vaccine candidate
- (2018) Jyotiranjan Bal et al. Microbial Cell Factories
- Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy
- (2018) Saranya Sridhar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pichia pastoris-Expressed Bivalent Virus-Like Particulate Vaccine Induces Domain III-Focused Bivalent Neutralizing Antibodies without Antibody-Dependent Enhancement in Vivo
- (2018) Rahul Shukla et al. Frontiers in Microbiology
- Dengue vaccine: reliably determining previous exposure
- (2018) Kevin K Ariën et al. Lancet Global Health
- Safety and Immunogenicity of a Tetravalent Live-attenuated Dengue Vaccine in Flavivirus Naive Children
- (2018) Sriluck Simasathien et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Recent Developments in Recombinant Protein–Based Dengue Vaccines
- (2018) Nagesh K. Tripathi et al. Frontiers in Immunology
- A recombinant live attenuated tetravalent vaccine for the prevention of dengue
- (2017) Bruno Guy et al. Expert Review of Vaccines
- Molecular engineering and plant expression of an immunoglobulin heavy chain scaffold for delivery of a dengue vaccine candidate
- (2017) Mi-Young Kim et al. PLANT BIOTECHNOLOGY JOURNAL
- Elaboration of tetravalent antibody responses against dengue viruses using a subunit vaccine comprised of a single consensus dengue envelope sequence
- (2017) Jin Sun et al. VACCINE
- Towards development of a universal dengue vaccine – How close are we?
- (2017) Ee Leen Pang et al. Asian Pacific Journal of Tropical Medicine
- The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge model
- (2016) Beth D. Kirkpatrick et al. Science Translational Medicine
- Recombinant lipidated dengue-3 envelope protein domain III stimulates broad immune responses in mice
- (2016) Chen-Yi Chiang et al. VACCINE
- Immunogenicity of a novel tetravalent vaccine formulation with four recombinant lipidated dengue envelope protein domain IIIs in mice
- (2016) Chen-Yi Chiang et al. Scientific Reports
- Vaccines and immunization strategies for dengue prevention
- (2016) Yang Liu et al. Emerging Microbes & Infections
- Guiding dengue vaccine development using knowledge gained from the success of the yellow fever vaccine
- (2015) Huabin Liang et al. Cellular & Molecular Immunology
- Development of TV003/TV005, a single dose, highly immunogenic live attenuated dengue vaccine; what makes this vaccine different from the Sanofi-Pasteur CYD™ vaccine?
- (2015) Stephen S. Whitehead Expert Review of Vaccines
- Robust and Balanced Immune Responses to All 4 Dengue Virus Serotypes Following Administration of a Single Dose of a Live Attenuated Tetravalent Dengue Vaccine to Healthy, Flavivirus-Naive Adults
- (2015) Beth D. Kirkpatrick et al. JOURNAL OF INFECTIOUS DISEASES
- Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease
- (2015) Sri Rezeki Hadinegoro et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity
- (2015) Naphak Modhiran et al. Science Translational Medicine
- Modelling the immunological response to a tetravalent dengue vaccine from multiple phase-2 trials in Latin America and South East Asia
- (2015) Ilaria Dorigatti et al. VACCINE
- Preclinical development of a dengue tetravalent recombinant subunit vaccine: Immunogenicity and protective efficacy in nonhuman primates
- (2015) Dhanasekaran Govindarajan et al. VACCINE
- Mouse models of dengue virus infection for vaccine testing
- (2015) Vanessa V. Sarathy et al. VACCINE
- Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial
- (2014) Maria Rosario Capeding et al. LANCET
- Evaluation in mice of the immunogenicity and protective efficacy of a tetravalent subunit vaccine candidate against dengue virus
- (2014) Laura Lazo et al. MICROBIOLOGY AND IMMUNOLOGY
- Induction of Neutralizing Antibodies against Four Serotypes of Dengue Viruses by MixBiEDIII, a Tetravalent Dengue Vaccine
- (2014) Hui Zhao et al. PLoS One
- Recombinant lipidated dengue-4 envelope protein domain III elicits protective immunity
- (2014) Chen-Yi Chiang et al. VACCINE
- A tetravalent alphavirus-vector based dengue vaccine provides effective immunity in an early life mouse model
- (2014) Syed Muaz Khalil et al. VACCINE
- Utility, Limitations, and Future of Non-Human Primates for Dengue Research and Vaccine Development
- (2014) Carlos A. Sariol et al. Frontiers in Immunology
- A consensus envelope protein domain III can induce neutralizing antibody responses against serotype 2 of dengue virus in non-human primates
- (2013) Hsin-Wei Chen et al. ARCHIVES OF VIROLOGY
- Current state and recent advances in biopharmaceutical production in Escherichia coli, yeasts and mammalian cells
- (2013) Aleš Berlec et al. JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY
- A Single Dose of Any of Four Different Live Attenuated Tetravalent Dengue Vaccines Is Safe and Immunogenic in Flavivirus-naive Adults: A Randomized, Double-blind Clinical Trial
- (2013) Anna P. Durbin et al. JOURNAL OF INFECTIOUS DISEASES
- Interactions between serotypes of dengue highlight epidemiological impact of cross-immunity
- (2013) N. G. Reich et al. Journal of the Royal Society Interface
- An Alphavirus Vector-Based Tetravalent Dengue Vaccine Induces a Rapid and Protective Immune Response in Macaques That Differs Qualitatively from Immunity Induced by Live Virus Infection
- (2013) L. J. White et al. JOURNAL OF VIROLOGY
- Correction: An Explosive Epidemic of DENV-3 in Cairns, Australia
- (2013) Scott A. Ritchie et al. PLoS One
- Symptomatic Versus Inapparent Outcome in Repeat Dengue Virus Infections Is Influenced by the Time Interval between Infections and Study Year
- (2013) Magelda Montoya et al. PLoS Neglected Tropical Diseases
- Neutralization of dengue virus in the presence of Fc receptor-mediated phagocytosis distinguishes serotype-specific from cross-neutralizing antibodies
- (2012) Ryan S.L. Wu et al. ANTIVIRAL RESEARCH
- Eliciting cross-neutralizing antibodies in mice challenged with a dengue virus envelope domain III expressed in Escherichia coli
- (2012) Jie Yang et al. CANADIAN JOURNAL OF MICROBIOLOGY
- Using recombinant DNA technology for the development of live-attenuated dengue vaccines
- (2012) Hsiang-Chi Lee et al. ENZYME AND MICROBIAL TECHNOLOGY
- Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial
- (2012) Arunee Sabchareon et al. LANCET
- Development of dengue DNA vaccines
- (2011) Janine R. Danko et al. VACCINE
- Development and clinical evaluation of multiple investigational monovalent DENV vaccines to identify components for inclusion in a live attenuated tetravalent DENV vaccine
- (2011) Anna P. Durbin et al. VACCINE
- Immunogenicity and efficacy of chimeric dengue vaccine (DENVax) formulations in interferon-deficient AG129 mice
- (2011) Joseph N. Brewoo et al. VACCINE
- Review of dengue virus and the development of a vaccine
- (2010) Sarah Murrell et al. BIOTECHNOLOGY ADVANCES
- Expression of dengue virus E glycoprotein domain III in non-nicotine transgenic tobacco plants
- (2010) Mi-Young Kim et al. BIOTECHNOLOGY AND BIOPROCESS ENGINEERING
- Development of a recombinant tetravalent dengue virus vaccine: Immunogenicity and efficacy studies in mice and monkeys
- (2010) David E. Clements et al. VACCINE
- Evaluation of a prototype dengue-1 DNA vaccine in a Phase 1 clinical trial
- (2010) Charmagne G. Beckett et al. VACCINE
- An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity
- (2009) Saima Khanam et al. VACCINE
- Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses
- (2009) Bruno Guy et al. VACCINE
- Dengue virus neutralization is modulated by IgG antibody subclass and Fcγ receptor subtype
- (2009) W.W. Shanaka I. Rodrigo et al. VIROLOGY
- Protection against dengue virus by non-replicating and live attenuated vaccines used together in a prime boost vaccination strategy
- (2009) Monika Simmons et al. VIROLOGY
- Mouse models of dengue virus infection and disease
- (2008) L YAUCH et al. ANTIVIRAL RESEARCH
- Dengue-4 envelope domain III fused twice within the meningococcal P64k protein carrier induces partial protection in mice
- (2008) Laura Lazo et al. BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY
- A Tetravalent Dengue Vaccine Based on a Complex Adenovirus Vector Provides Significant Protection in Rhesus Monkeys against All Four Serotypes of Dengue Virus
- (2008) K. Raviprakash et al. JOURNAL OF VIROLOGY
- Immunogenicity of a recombinant envelope domain III protein of dengue virus type-4 with various adjuvants in mice
- (2008) J. Pradeep Babu et al. VACCINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now